MAR 16, 2015 11:06 AM PDT

'Warhead' Molecule to Hunt Down Deadly Bacteria

WRITTEN BY: Judy O'Rourke
Targeting deadly, drug-resistant bacteria poses a serious challenge to researchers looking for antibiotics that can kill pathogens without causing collateral damage in human cells. A team of Boston College chemists details a new approach using a "warhead" molecule to attack bacteria -- and spare healthy human cells -- by targeting a pair of lipids found on the surface of deadly germs, according to a report today in the journal Nature Communications.

The new strategy required the researchers to develop a novel type of "warhead molecule" capable of selectively targeting bacteria, overcoming biological conditions that interfere with bonding to pathogens and avoiding healthy human cells, says Jianmin Gao, PhD, associate professor of chemistry and the lead author of the report.
This is a colorized scanning electron micrograph of a white blood cell eating an antibiotic resistant strain of Staphylococcus aureus bacteria (MRSA).
The BC team found answers to those challenges in the covalent chemistry of lipids, Gao says.

"In contrast to other efforts focused on the charge-to-charge attraction between molecules, we are using a completely different mechanism to target bacterial cells," Gao says. "Our method exploits the covalent chemistry of lipids -- where the lipids react with synthetic molecules to form new chemical structures based on the formation of new covalent bonds."

Pathogenic bacteria that are resistant to conventional antibiotics pose increasingly serious threats to public health. Researchers in medicinal chemistry, particularly those who seek to develop new antibiotics, are constantly looking for new ways to identify and differentiate bacterial pathogens from host cells within the human body.

Gao says bacterial cells are known to display a different set of lipids in their membranes. Prior research has focused on the use of positively charged peptides to target negatively charged lipids on the surface of bacterial cells. The approach has seen limited success as the charge-charge attraction between the attacking molecules and bacteria is prone to weakening by the presence of salt and other molecules, said Gao.

The researchers developed a novel, unnatural amino acid that serves as a suitable molecular warhead to target bacterial pathogens. Gao and his group sent the warhead molecule after bacterial lipids known as amine-presenting lipids -- specifically phosphatidylethanolamine (PE) and lysyl phosphatidylglycerol (Lys-PG) -- which can be selectively derivatized to form iminoboronates, a covalent bond forming process that allows the selective recognition and labeling of bacterial cells.

In addition, because amine-presenting lipids are scarce on the surface of mammalian cells, they are able to seek out and label bacterial cells with a high degree of selectivity, Gao says. Furthermore, iminoboronate formation can be reversed under physiologic conditions, giving the new method a high degree of control and allowing the warhead molecules to self-correct if unintended targets are reached.

Gao says a large number of bacterial species present PE and Lys-PG on their surfaces, making the covalent labeling strategy applicable to many applications in the diagnosis of bacterial infections and the delivery of antibiotic therapies.

"For the short term, we hope this work will inspire other people to consider using covalent chemistry for interrogating biological systems," Gao says. "Going into the future, we are excited to explore the potential of our chemistry for imaging bacterial infections. We are also working hard to apply our current findings to facilitate the targeted delivery of potent antibiotics to bacterial cells only."

[Source: Boston College]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
SEP 27, 2018
Microbiology
SEP 27, 2018
How Bacterial Cells Take out the Trash
Some types of bacteria create tiny versions of themselves that cannot reproduce - miniature spheres lacking chromosomal DNA that are known as minicells....
SEP 30, 2018
Drug Discovery
SEP 30, 2018
Researchers Re-classify the 'Magic Mushroom' Drug
Researchers at John Hopkins have evaluated the safety and efficacy of compound, psilocybin, found in hallucinogenic mushrooms. They suggested that if evalu...
OCT 02, 2018
Drug Discovery
OCT 02, 2018
Mycobacterial Lung Disease, FDA Approves New Drug
New drug seeking to treat antibiotic-resistant lung disease has just been approved by the U.S. Food and Drug Administration. The drug is called ‘Arik...
OCT 25, 2018
Microbiology
OCT 25, 2018
Common Herbicides Increase Antibiotic Resistance
If we have to feed a growing planet, it may hurt us in the long run if the methods used in farming are actually increasing antibiotic-resistance in bacteria....
OCT 24, 2018
Drug Discovery
OCT 24, 2018
Silver Nanoparticles Coat Anti-seizure Drugs To Combat Brain-Eating Amoebae
Since Halloween is around the corner, it is science-fiction season and some may choose to celebrate by watching movies featuring brain-eating zombies. Howe...
NOV 05, 2018
Microbiology
NOV 05, 2018
Potential Antidote to Botulism is Found
A microbe called Clostridium botulinum and sometimes two other strains of Clostridium bacteria can make a toxic chemical called botulism....
Loading Comments...